TYMS and colorectal carcinoma: It is the most widely studied prognostic and predictive marker in CRC, with low TS levels predicting a better outcome to 5-FU based chemotherapy (Aschele et al, 2002), and high TS expression being associated with a poor prognosis (Allegra et al, 2003).